PharmiWeb6d
Lundbeck’s potential treatment amlenetug for Multiple System Atrophy receives Fast Track Designation from the FDA
The FDA has granted Fast Track Designation to Lundbeck’s investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA). Lundbeck has recently initiated ...
H. Lundbeck A/S: Lundbeck's potential treatment amlenetug for Multiple System Atrophy receives Fast Track Designation from the FDA
The FDA has granted Fast Track Designation to Lundbeck's investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA).
themarijuanaherald3d
Study Finds “Cannabinoids Hold Significant Potential for Preventing and Treating Brain Diseases”
According to a new study published in the journal Cellular Signalling, cannabinoids may play a crucial role in preventing and ...
ALZFORUM5d
Does CSF Aβ Reflect Protofibril Concentration, Rather Than Plaques?
In related news, other scientists recently reported that phospho-tau isoforms in the CSF mirror protofibrillar forms of tau, ...
Medical Xpress5d
Medical economics news
Daily science news on research developments and the latest scientific innovations Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech ...